These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23014900)

  • 61. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.
    Karanasos A; Simsek C; Gnanadesigan M; van Ditzhuijzen NS; Freire R; Dijkstra J; Tu S; Van Mieghem N; van Soest G; de Jaegere P; Serruys PW; Zijlstra F; van Geuns RJ; Regar E
    J Am Coll Cardiol; 2014 Dec; 64(22):2343-56. PubMed ID: 25465421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coronary artery aneurysm formation within everolimus-eluting bioresorbable stent.
    Şerban R; Scridon A; Dobreanu D; Elkaholut A
    Int J Cardiol; 2014 Nov; 177(1):e4-5. PubMed ID: 25129265
    [No Abstract]   [Full Text] [Related]  

  • 63. PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
    Meredith IT; Whitbourn R; Scott D; El-Jack S; Zambahari R; Stone GW; Teirstein PS; Starzyk RM; Allocco DJ; Dawkins KD
    EuroIntervention; 2011 May; 7(1):84-90. PubMed ID: 21550907
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.
    Lee WC; Chung WJ; Fang HY; Wu CJ
    Int J Cardiol; 2016 Mar; 206():58-60. PubMed ID: 26774833
    [No Abstract]   [Full Text] [Related]  

  • 65. Coronary Artery Aneurysm After Everolimus-Eluting Bioabsorbable Vascular Scaffold Implantation.
    Varghese S; Lauer B; Ohlow MA
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e23-5. PubMed ID: 26793967
    [No Abstract]   [Full Text] [Related]  

  • 66. Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
    Fajadet J; Wijns W; Laarman GJ; Kuck KH; Ormiston J; Baldus S; Hauptmann KE; Suttorp MJ; Drzewiecki J; Pieper M; Schultheiss HP; Mauri L
    EuroIntervention; 2010 Nov; 6(5):562-7. PubMed ID: 21044908
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial].
    Achremczyk M
    Kardiol Pol; 2012; 70(7):762-3. PubMed ID: 22825959
    [No Abstract]   [Full Text] [Related]  

  • 68. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 69. Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial.
    Moreno R; García E; Teles R; Rumoroso JR; Cyrne Carvalho H; Goicolea FJ; Moreu J; Mauri J; Sabaté M; Mainar V; Patricio L; Valdés M; Fernández Vázquez F; Sánchez-Recalde A; Galeote G; Jimenez-Valero S; Almeida M; Lopez de Sa E; Calvo L; Plaza I; Lopez-Sendón JL; Martín JL;
    Circ Cardiovasc Interv; 2013 Feb; 6(1):21-8. PubMed ID: 23403384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process.
    Sarno G; Onuma Y; Garcia Garcia HM; Garg S; Regar E; Thuesen L; Dudek D; Veldhof S; Dorange C; Ormiston JA; Serruys PW
    Catheter Cardiovasc Interv; 2010 May; 75(6):914-8. PubMed ID: 20091822
    [TBL] [Abstract][Full Text] [Related]  

  • 71. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.
    Räber L; Wohlwend L; Wigger M; Togni M; Wandel S; Wenaweser P; Cook S; Moschovitis A; Vogel R; Kalesan B; Seiler C; Eberli F; Lüscher TF; Meier B; Jüni P; Windecker S
    Circulation; 2011 Jun; 123(24):2819-28, 6 p following 2828. PubMed ID: 21646500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Three-dimensional reconstruction of the post-dilated ABSORB everolimus-eluting bioresorbable vascular scaffold in a true bifurcation lesion for flow restoration.
    Gogas BD; van Geuns RJ; Farooq V; Regar E; Heo JH; Ligthart J; Serruys PW
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1149-50. PubMed ID: 22017943
    [No Abstract]   [Full Text] [Related]  

  • 74. Simplifying the double kissing (DK) crush with the use of bioresorbable scaffolds.
    Panoulas VF; Sato K; Miyazaki T; Kawamoto H; Latib A; Colombo A
    Int J Cardiol; 2015 Oct; 196():139-42. PubMed ID: 26093528
    [No Abstract]   [Full Text] [Related]  

  • 75. Shedding light on scaffold vascular response.
    Gogas BD; Samady H
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1370-3. PubMed ID: 25523530
    [No Abstract]   [Full Text] [Related]  

  • 76. Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives.
    Brugaletta S; Garcia-Garcia HM; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2012 Jul; 9(4):327-38. PubMed ID: 22420293
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is Multislice Computed Tomography a Feasible Option for Follow-Up of Complex Coronary Lesions Treated With Bioresorbable Scaffolds?
    Regazzoli D; Latib A; Tanaka A; Di Marco D; Giglio M; Jabbour R; Ancona MB; Leone PP; Mangieri A; Montorfano M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2578-2581. PubMed ID: 28007208
    [No Abstract]   [Full Text] [Related]  

  • 78. First European implantation of the new, thin-strut, sirolimus-eluting bioresorbable scaffold.
    Kochman J; Kołtowski Ł; Abizaid A; Tomaniak M; Stanecka P
    Kardiol Pol; 2015; 73(3):224. PubMed ID: 25791978
    [No Abstract]   [Full Text] [Related]  

  • 79. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S
    Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328
    [No Abstract]   [Full Text] [Related]  

  • 80. Imaging assessment of bioresorbable vascular scaffolds.
    Sotomi Y; Suwannasom P; Tenekecioglu E; Collet C; Nakatani S; Okamura T; Muramatsu T; Ishibashi Y; Tateishi H; Miyazaki Y; Asano T; Katagiri Y; von Zur Muehlen C; Tanabe K; Kozuma K; Ozaki Y; Serruys PW; Onuma Y
    Cardiovasc Interv Ther; 2018 Jan; 33(1):11-22. PubMed ID: 28766253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.